Last update 01 Nov 2024

Quantum Genomics Corp.

Private Company|
New Jersey, United States

Overview

Tags

Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
gp160(Glutamyl aminopeptidase)2

Related

3
Drugs associated with Quantum Genomics Corp.
Firibastat
Target
gp160
Mechanism
gp160 inhibitors
Active Org.
Quantum Genomics Corp. [+1]
Originator Org.
Quantum Genomics SAQuantum Genomics SA
Active Indication
Hypertension [+1]
Inactive Indication
Acute myocardial infarction [+8]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
QGC-006
Target
gp160
Mechanism
gp160 inhibitors
Active Org.
Quantum Genomics Corp.
Originator Org.
Quantum Genomics Corp.
Active Indication
Heart Failure [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
QGC-002
Target-
Mechanism-
Active Org.-
Originator Org.
Atos SEAtos SE
Active Indication-
Inactive Indication
Myocardial Ischemia [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Quantum Genomics Corp.
Login to view more data
0 Patents (Medical) associated with Quantum Genomics Corp.
Login to view more data
100 Deals associated with Quantum Genomics Corp.
Login to view more data
100 Translational Medicine associated with Quantum Genomics Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 3 Clinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Firibastat
 ( gp160 )		Hypertension
More
Phase 3
QGC-006
 ( gp160 )		Hypertension
More
Preclinical
QGC-002
Stroke
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free